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ABSTRACT - Purpose. Polymeric porous foams have been evaluated as possible new pharmaceutical 
dosage forms. Methods. These materials were obtained by polymerization in the continuous phase of highly 
concentrated emulsions prepared by the phase inversion temperature method. Their porosity, specific surface 
and surface topography were characterized, and the incorporation and release of active principles was 
studied using ketoprofen as model lipophilic molecule. Results. Solid foams with very high pore volume, 
mainly inside macropores, were obtained by this method. The pore morphology of the materials was 
characterized, and very rough topography was observed, which contributed to their nearly superhydrophobic 
properties. These solid foams could be used as delivery systems for active principles with pharmaceutical 
interest, and in the present work ketoprofen was used as a model lipophilic molecule. Conclusions. Drug 
incorporation and release was studied from solid foam disks, using different concentrations of the loading 
solutions, achieving a delayed release with short lag-time.  
 
This article is open to POST-PUBLICATION REVIEW. Registered readers (see “For 
Readers”) may comment by clicking on ABSTRACT on the issue’s contents page. 
____________________________________________________________________ 
 
INTRODUCTION 
 
Foams (understood as coarse dispersions of gas 
bubbles in liquids) find applications in pharmacy 
as aqueous and non-aqueous spray preparations 
for topical, rectal and vaginal medications and for 
burn dressings. Because of their high interfacial 
area and relatively high interfacial tension, foams 
are unstable in the thermodynamic sense (1,2). On 
another hand, solid foams are stable, can be 
prepared from many different materials 
(polymers, ceramics, metals and their composites) 
and have been studied for their potential use as 
implants in tissue engineering applications. As 
illustration, several patents and articles (3-9) have 
described biopolymer or calcium phosphate foams 
for tissue repair and reconstruction containing 
collagen and calcium phosphate, hydroxyapatite 
or demineralized bone. Other examples include 
collagen foams used as hemostatic agents (10), 
scaffolds for tissue repair (11), and supports for 
cell growth (12). Recently, three-dimensional 
scaffolds have been designed to mimic bone-
forming characteristics of autografts, such as 
chemical composition (13,14) or microstructure 
(15,16), in order to facilitate vascularization in the 
material and provide a suitable environment for 
bone formation (13–16). 
Porous materials constitute an integral part of 
various dosage forms (17). The porous network is 
important in determining both natural and 
practical applications such as dissolution, 
adsorption and diffusion of drugs (18). In recent 
years, the use of mesoporous materials for hosting 
and further delivering of a variety of molecules of 
pharmaceutical interest has been described (19, 
20). It has been shown that both small and large 
molecules can be entrapped within the mesopores 
by an impregnation process and released via a 
diffusion-controlled mechanism (21). In this 
context, porous materials may have several 
attractive features, such as high surface areas, 
tunable pore sizes with narrow distributions and 
well-defined surface properties, thus allowing the 
adsorption and release of certain kinds of drugs in 
a more reproducible and predictable manner (22). 
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Porous materials are well known for a variety 
of uses, from molecular sieves to catalysis (23, 
24), and the introduction of pores in the range 
from macro (>50 nm), meso (2-50 nm) and micro 
(<2 nm), in an ordered way, is important for 
specific applications. Most synthetic methods to 
produce hierarchical porous structures are 
laborious multi-step processes and consequently 
simple methods are of interest (25). For instance, 
polystyrene (PS) solid foams have traditionally 
been prepared by extrusion with a blowing agent 
or by expansion of polystyrene beads, and 
consequently these porous foams are often made 
of closed macropores (not interconnected) with 
limited absorption and release properties. They 
are generally used as packaging materials, as 
insulating materials (26) or for heavy metal 
removal from industrial effluents (27). 
As an alternative for conventional methods 
for preparing solid foams, emulsions can be used 
as templates for producing either particles or 
porous scaffolds when selecting the disperse 
phase of the emulsion or the continuous phase for 
polymerization (25,28). The polymerization of the 
continuous phase of a highly concentrated 
emulsion, followed by the removal of the internal 
phase, leads to the formation of solid foams with 
very high pore volume (29, 30). For instance, 
solid polystyrene foams, with very large pore 
volumes (≥15 mL/g) have been prepared with a 
relatively narrow pore size distribution. Such 
foams have been obtained by polymerization in 
the continuous phase of highly concentrated 
water-in-styrene emulsions stabilized by nonionic 
surfactants. These emulsions can be prepared by a 
method based on the phase inversion temperature 
(PIT) (31). Low-energy emulsification methods 
like PIT, make use of the phase transitions taking 
place during the emulsification process to produce 
highly concentrated emulsions almost 
spontaneously (32-34). PIT method is based on 
solubility changes, with temperature, of 
polyoxyethylene-type nonionic surfactants. These 
surfactants become more lipophilic with 
increasing temperature due to dehydration of the 
polyoxyethylene chains. At low temperature, the 
surfactant monolayer has a large positive 
spontaneous curvature forming oil- swollen 
micellar solutions (O/W microemulsions) which 
may coexist with an excess oil phase dispersed as 
O/W emulsion droplets. At high temperatures, the 
spontaneous curvature becomes negative and 
water-swollen reverse micelles (W/O 
microemulsions) coexist with excess water phase, 
leading to W/O emulsions. There is an 
intermediate temperature (the HLB temperature), 
where the spontaneous curvature becomes close 
to zero and a bicontinuous microemulsion, D 
phase, containing comparable amounts of water 
and oil, coexists with both excess water and oil 
phases (31). The PIT emulsification method takes 
advantage of the extremely low interfacial 
tensions achieved at the HLB temperature (31), to 
promote emulsification. However, coalescence 
rate at the HLB temperature is rather fast and the 
emulsions are very unstable, although 
emulsification is favored. This problem is 
overcome by rapidly changing the temperature 
(by about 25–30 ºC) of emulsions prepared at the 
HLB temperature. Rapid cooling or heating 
allows to obtain kinetically stable emulsions 
(O/W or W/O, respectively) with very small 
droplet size and narrow size distribution (34). 
By polymerization of one or more monomers 
in the external phase of such emulsions, PS 
macroporous foams could be obtained with 
controlled pore morphology and although this 
polymer is not biocompatible, the study of its 
drug delivery properties obtained could serve as a 
model for future works. 
The porous structure of solid foams prepared 
from highly concentrated emulsions, somehow 
mimicking the inner bone structure, suggests 
biomedical applications, such as implants or 
prostheses, and consequently the solid foams 
could be used as vehicles for therapeutic agents. 
Although application of biomaterials has been one 
of the major assets in modern medicine to 
improve the quality of life of patients, there are 
still several issues to be improved. For instance, 
occurrence of biomaterial related infections is still 
a serious health threat to the individual patient, 
and to avoid systemic antibiotic administration, 
local drug delivery systems are under study (35). 
Another issue to be addressed in biomaterials is 
enhancing healing conditions after implantation, 
and limiting or avoiding inflammatory processes 
could be an interesting achievement. 
Drugs with small molecular weight that 
control proliferation or differentiation of cells 
have been incorporated into biodegradable 
scaffolds to induce cellular differentiation and 
tissue remodeling. For example, dexamethasone, 
a steroidal anti-inflammatory drug, was loaded 
into the inner surface phase of PLGA scaffolds 
for sustained release (36). It was observed that 
sustained release of dexamethasone effectively 
induced differentiation of bone marrow stem cells 
to osteoblasts or chondrocytes (37). 
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In the present work, polystyrene-
divinylbenzene macroporous solid foams were 
prepared from highly concentrated emulsions by 
the PIT method, and characterized by different 
techniques. The novelty of the present study lays 
on evaluating the influence of the porous 
structure, surface area and other characteristics, 
derived from the emulsion-template used, on the 
release of drugs. Ketoprofen, a potent non-
steroidal anti-inflammatory drug (NSAID), has 
been widely used for the treatment of rheumatoid 
arthritis and related diseases (38). However, it 
accompanies adverse side effects including 
gastrointestinal irritation when administered 
orally. Since ketoprofen is usually given to 
patients over an extended period, efforts to reduce 
its adverse side effects have been attempted, so 
new forms are of interest in this field. Thus, the 
polymers were selected for their inertness towards 
a lipophilic model drug, to eliminate other 
possible interactions. Similar structures could 
constitute dosage forms, so the incorporation of 
ketoprofen to the synthesised solid foams requires 
specific study.  
  
MATERIALS AND METHODS 
 
Materials 
All surfactants, hexaethylene glycol n-hexadecyl 
ether, octaethylene glycol n-dodecyl ether, 
abbreviated as C16(OE)6 and C12(EO)8, 
respectively, (Nikko Chemicals Co., Japan) and 
Synperonic L64 (ICI,  Belgium) were used 
without further purification. Styrene and 
divinylbenzene (Merck), abbreviated respectively 
as S and DVB, were purified by elution through 
neutral chromatographic aluminum oxide, to 
eliminate the inhibitor, which is a nonvolatile 
polar compound. Initiator potassium persulfate 
99% (Fluka), as well as tetradecane 99% (Merck), 
were used as received. 
 
 
Figure 1. Molecular structure of ketoprofen 
 
Ketoprofen 99.8% (2-(3-benzoylphenyl)propanoic 
acid) (Fagron, Spain), was used as model 
lipophilic molecule for drug delivery (Fig. 1). 
Phosphate buffer solution (PBS) (pH=7.4) was 
prepared from sodium phosphate, potassium 
phosphate and sodium chloride, all purchased 
from Merck. The dialysis bags were porous 
cellulose membranes (Orange Scientific) with a 
molecular weight cut off (MWCO) of 12000-
14000, which allows dialysis of ketoprofen. 
 
Preparation of the solid foams 
 
Highly Concentrated Emulsions 
The emulsions were prepared from the system 
H2O / K2S2O8 / C16(EO)6 / C12(EO)8 / Synperonic 
L-64 / styrene / divinylbenzene / tetradecane 
(89.9/0.1/1.2/0.7/0.1/4.0/1.0/3.0 wt %), which was 
prepared as described in the literature (25). 
Samples were weighted into glass tubes. The 
emulsions had a weight fraction of the disperse 
phase equal to 0.9 and were prepared by first 
cooling to 0 °C. They were vibromixer stirred, 
and temperature was quickly increased to 60 °C 
by placing the samples into a water bath of such 
temperature, with constant vibromixer agitation, 
finishing with manual agitation to help phase 
inversion. 
 
Polymerization 
Solid PS-DVB foams were prepared by reactions 
in the continuous phase of highly concentrated 
W/O emulsions. The emulsions were kept in 
sealed glass tubes at 60 °C for 48 h, allowing 
polymerization to take place. The wet polystyrene 
monoliths were then removed by carefully 
breaking the glass containers. These monoliths 
were handled cautiously as they were very fragile 
at this stage. The monoliths were dried at ambient 
temperature, and were then carefully sliced with a 
sharp rotary blade into 1-2 mm cylinders of 25 
mm diameter. They were washed firstly with 
water and secondly with ethanol, at 60°C with a 
solvent volume at least 10 times higher than the 
sample volume, and then Soxhlet extracted with 
ethanol to ensure the removal of all the products 
but polystyrene. Finally, samples were dried by 
placing them into an oven at 70 °C, until weight 
was constant. 
 
Milling of the samples 
The solid PS-DVB cylinders (disks) were ground 
with a rotary ball mill Mixer Mill MM 200 
(Retsch) with two 7.15g stainless steel balls and a 
ball to powder ratio of 15, at 250 rpm for 3 min.  
 
Scanning Electron Microscopy 
Topography of the samples was studied by using 
a Hitachi S-4100 Field Emission Scanning 
Electron Microscope (SEM). Previous to 
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observation, samples were carbon coated by 
sputtering.  
 
Determination of specific surface area, total 
mesopore volume and pore size by Nitrogen 
sorption  
The nitrogen isotherms were obtained at 77K 
using a Micromeritics, Tristar 3000 apparatus. 
The total mesopore volume, corresponding to the 
volume of pores smaller than ≈200 nm, was 
obtained from the isotherms at 0.99 partial 
pressure. The specific surface area was 
determined from the adsorption isotherm by 
applying the BET theory (39) to the low pressure 
region, where the volume of a N2 adsorbed 
monolayer Vm, is calculated by linear fitting of 
equation [1]. 
 
 
ଵ
௏ቂቀುబು ቁିଵቃ
ൌ ௖ିଵ௏೘ ቀ
௉
௉బቁ ൅
ଵ
௏೘௖    [1] 
 
 
where P and P0 are respectively the equilibrium 
and the saturation pressure of adsorbate (i.e. N2), 
V is the adsorbed volume, and c is the BET 
constant related to the difference between the 
energy of adsorption and the energy of 
liquefaction. The specific surface area, generally 
denoted as SBET, can be calculated from Vm and 
the cross-section area of a N2 molecule. 
The pore size distribution was obtained by 
using the BJH method (40) applied to the 
desorption curves. This method is based on 
Kelvin equation [eq. 2], that estimates the 
pressure at which the adsorbate will evaporate 
from a cylindrical pore of a given size. This 
allows to calculate the pore size from the 
desorption isotherm.  
 
 
ln ቀ୔∗୔బቁ ൌ െቀ
ଶஓ஝ cos஘
ୖ୘୰ౣ ቁ  [2] 
 
 
where P* is the critical condensation pressure,  
the liquid surface tension, the molar volume of 
the condensed adsorbate,  the contact angle 
between the solid and condensed phase (taken to 
be zero when the adsorbate is nitrogen, hence cos 
 = 1), rm the mean radius of curvature of the 
liquid meniscus, R is the universal gas constant 
and T the absolute temperature.  
 
 
Drug loading 
Ketoprofen was incorporated into the PS-DVB 
porous materials from solutions in EtOH/H2O 1:1 
w/w, either by slow droplet addition or by 
immersion of the samples in the drug solution. 
Solvent was evaporated at 50ºC for 24h until 
weight was constant.  
 
Drug delivery experiments 
The diffusion experiments were carried out 
according to previous works (41). Samples were 
placed in dialysis bags, which were filled with 
phosphate buffer solution (PBS) and submerged 
in diffusion cells containing 150 ml of PBS. The 
diffusion cells consisted on a cylindrical 
thermojacketed amber glass vessel connected to a 
water bath at fixed temperature (37ºC) and closed 
to avoid loss of receptor solution due to 
evaporation. The receptor solutions were stirred 
by means of a magnetic stirrer. 
Periodically, samples (1 mL) were withdrawn 
for determination of ketoprofen concentration by 
UV spectrophotometry (=233nm). In order to 
maintain constant the volume of the receptor 
solution, 1 mL of fresh PBS solution was added to 
the receptor bath after each withdrawal. This 
small dilution effect was taken into account in the 
calculations of the % released. 
The solubility of ketoprofen in PBS at 
pH=7.4, as used in this study, is 0.4%. Prior to the 
experiments, it was calculated that even if the 
total of ketoprofen present in the solid foams was 
completely released, still in that case, and 
considering the volume of the release media, the 
ketoprofen dissolved would be below the 20% of 
its maximum solubility in PBS. Therefore, sink 
conditions were ensured in these experiments. 
At least four replicates have been studied in 
each case. The experimental error has been 
calculated as the standard deviation. Statistical 
differences were determined using one-way 
ANOVA with Tukey's post-tests using Minitab 16 
software (Minitab, Inc., US). Statistical 
significance was noted when p < 0.05. 
 
RESULTS 
 
As shown by SEM (Fig. 2), the PS-DVB 
materials studied in this work contain 
polydisperse macropores, preserving the structure 
of the continuous phase of the emulsion which 
served as template for polymerization (Fig. 2a). 
Such macropores are interconnected by holes of 
smaller diameter. For the drug delivery 
experiments, samples of 25 mm diameter,       
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have been sliced into disks of 1-2mm thickness. 
In that case, two surfaces with different 
topography can be clearly distinguished; that of 
the inner surface, already described and shown in 
Fig. 2a, and that of the skin layer, shown in Fig. 
2b. 
Macropores of the solid foam disks are in the 
range of 5-10 m, being the largest macropores 
around 30 m, and the smallest around 600 nm. 
The possible presence of mesopores (0.2-50 nm) 
was evaluated through Nitrogen sorption 
experiments (Fig. 3). The volume of mesopores is 
relatively low (the single point method provided a 
mesopore volume of 0.25 cm3/g for the disks, 
indicated in Table 1), and much smaller than the 
total pore volume of the solid foam materials  
≈20 cm3/g-1) (42). 
 
  
Figure 2. Micrographs of the polystyrene solid foams: (a) inner surface region, (b) skin layer polymerized in contact 
with the container walls and (c) powders obtained from the ground solid foams. 
 
Figure 3. Mesopore size distribution depending on the form (disc or powder) of the solid foams, calculated from the 
desorption curve by applying the BJH model. 
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In order to prepare another material form, the 
solid foam materials were ground to powder with 
a rotary ball mill. The grinding process to obtain 
powders from the materials has not only strongly 
affected the macropores, as shown by SEM (Fig. 
2c), but also the mesopores. This can be seen 
through the great reduction in surface area from 
80 m2/g, of PS-DVB solid foam disks, to 4 m2/g 
of PS-DVB powders (Table 1). The volume of 
mesopores determined by Nitrogen sorption 
experiments, already small, is also considerably 
reduced. 
Impregnation (Table 2) is the critical point of 
the drug incorporation process since the size and 
shape of the solid foam form will determine the 
amount of drug loaded into the material. Two 
impregnation methods were evaluated: a) droplet 
addition of the drug containing solution to the 
materials, or b) immersion of the materials in the 
drug containing solution. It was observed (Table 
2) that weight uptake does not depend much on 
impregnation method. The results are not 
statistically different, since the small differences 
are within the experimental error. 
The difficulties with impregnation lead to 
discard the materials in powder form. With solid 
foam disks, the droplet addition method did not 
allow uniform imbibing throughout the disk, 
which resulted in higher dispersion in the 
ketoprofen loaded to and released from the solid 
foam disks. However, the ketoprofen loaded to 
and released from solid foam disks using the 
immersion method provided results of the same 
order of magnitude and lower dispersion values, 
which indicates the suitability of the method. 
Weight uptake of the solid foam disks, 
impregnated by immersion with ketoprofen 
solutions of varying concentration, increases 
progressively with increasing ketoprofen 
concentration in the solution, as shown in Fig. 4, 
with values ranging from 26 to 68wt% weight 
uptake in solutions containing from 2 to 10wt% 
ketoprofen, respectively. Therefore, one can 
conclude that drug uptake is highly dependent on 
ketoprofen concentration, with statistically 
different values, since the weight increase is much 
higher than the experimental error. 
Figure 5 shows the drug delivery results of 
solid foam disks impregnated from the three 
different ketoprofen concentrations loaded onto 
the materials, and from a 2wt% PBS solution, to 
compare the influence of the material structure. 
Burst release, close to 100% in only 3 h, was 
registered for the 2% ketoprofen solution 
(indicated as * in Fig. 5), while slower kinetics 
were observed for the solid foam disks, which did 
not reach the stationary stage within the first 24 h 
(indicated as ** in Fig. 5). Maximum release 
around 80% was observed after 24 h, with no 
significant differences among the three differently 
loaded solid foams. 
 
 
 
 
Table 1. Main features of the porous PS-DVB solid foams as determined from Nitrogen sorption. The mesopore 
volume and the surface area were determined by the single point method and the BET equation, respectively. The 
value of the total pore volume was from the literature (42).
 Total pore volume 
(mL/g) 
Mesopore volume 
(cm3/g)  Surface area (m
2/g) 
Disks 20.5 ± 0.8  0.25 80 
Powders Not determined 0.03 4 
 
  
 
 
 
Table 2. Drug loaded from a 2% ketoprofen EtOH/H2O solution and released to a PBS solution PS-DVB disks 
with different impregnation methods 
Form Impregnation method % ketoprofen loaded (w/w) 
% ketoprofen released after 
24h 
Solid foam disk Droplet addition 25 ± 10 70 ± 17 
Solid foam disk Immersion 26 ± 1 79 ± 4 
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Figure 4. Ketoprofen uptake by the solid foam disks (in weight %) as a function of the % ketoprofen in the 
impregnating EtOH/H2O solution by the immersion method. The error bars indicate the standard deviation. 
 
 
 
 
Figure 5. Ketoprofen released from solid foam discs impregnated by immersion in EtOH/H2O solutions (1:1 w/w) 
containing three different ketoprofen concentrations:  2%, 5% and 10 %, and comparison with a 2% EtOH/H2O 
solution. (*) and (**) indicate the results from the control solution and from the foam disks, respectively. 
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DISCUSSION 
 
The present work characterizes and evaluates 
polystyrene-divinylbenzene macroporous 
materials (solid foams) as possible new vehicles 
for drug delivery. The solid foams obtained from 
the highly concentrated emulsions by the PIT 
method were, in the first place, characterized. 
Two monomers were present in the emulsion, 
styrene (S) and divinylbenzene (DVB), which 
reacted to form styrene-divinylbenzene (PS-DVB) 
copolymer, with DVB acting as crosslinking 
agent, which leads to solid foams with 
interconnected polydisperse macropores (Fig. 2a), 
according to the template set by the continuous 
phase of the emulsion. The phase inversion 
temperature method used for emulsification 
allowed obtaining the required pore 
interconnectivity, with views on allowing 
diffusion of drugs and flow of body fluids through 
the material. The highly concentrated emulsion 
has high volume of disperse phase and in that 
case, droplets are closely packed. Consequently, 
during polymerization of the continuous phase, in 
the regions where the continuous phase layer is 
too thin, a “hole” is formed between two pores 
thus producing the desired interconnectivity. 
SEM images reveal a different structure 
depending on the region (inner surface and skin 
layer) of the sample, with lower roughness on the 
skin layer with respect to the inner surface of the 
samples. The presence of a smooth skin layer can 
be explained by the contact with the glass surface 
of test tubes used as reactors (Fig. 2b), as 
observed in previous studies (42,43). 
Most of the pore volume of the solid foams is 
due to macropores, with a very small contribution 
of mesopores (approximately 99% of the pore 
volume is located in the macropores, estimated 
from the mesopore volume and the total pore 
volume resulting from the density). The small 
fraction of mesopores found in the materials, has 
a peak at 40 nm, in the pore size distribution 
calculated using BJH equations. This is consistent 
with the fact that the specific surface area (≈80 
m2/g) obtained is significantly smaller than typical 
mesoporous materials (44). 
The morphology of the materials is similar to 
that determined in previous works (42), although 
the surface area of the solid foam disks studied 
here is higher (nearly twofold) than that of 
monoliths with larger macropore size and higher 
polydispersity, as it is a parameter which is 
closely related with the structure of the materials. 
Grinding the materials to obtain a powder, 
which could be used as another form for drug 
delivery (PS-DVB powders), eliminated both the 
macropores, and the mesopores (Figs. 2c and 3). 
The grinding treatment produced a 95% reduction 
of the surface area with respect to the PS-DVB 
solid foam disks (Table 1). Obviously, this 
reduction in surface area and pore volume is due 
to a collapse of the porous structure of the 
materials during the grinding process. 
In addition to the morphological properties of 
the materials, their wetting properties are also of 
great relevance with views on incorporation and 
release of active principles. Conventional 
polystyrene films are hydrophobic with mean 
contact angle values of 103± 6º (43), but the 
particular characteristics of the material used in 
this work, with very high roughness (Fig. 2a) 
revealed highly hydrophobic properties (42). In 
general, materials with rough surfaces show 
higher contact angles than their smooth 
homologues. In previous studies it was observed 
that the inner surface follows the Cassie-Baxter 
behaviour (43, 45), and the measurement of 
advancing contact angle on the rough surface of 
the inner surface of the solid foam disks revealed 
a water contact angle of 143 ± 13º. Such high 
value, very close to superhydrophobic surfaces 
(46) comes from the combination of hydrophobic 
interactions and high roughness. The materials are 
thus mainly macroporous with interconnected 
pores, with high specific surface and highly 
hydrophobic wetting properties. 
Such hydrophobic surface is not wetted by 
water and would therefore impair incorporation of 
an active principle such as ketoprofen, to the 
foams from an aqueous solution. In addition, the 
measured solubility of ketoprofen in water is very 
low (0.014%), but it is freely soluble in ethanol. 
Therefore, a hydroalcoholic ketoprofen solution, 
which achieved good wetting of the samples due 
to its lower surface tension (=28.8 mN/m) than 
plain water (=72.8 mN/m), was used for the 
impregnation of the PS-DVB solid foam disks. As 
shown in Fig. 2, and also in accordance to 
previous papers (25), the pores of the material are 
interconnected, allowing a flow of the active 
principle solution throughout the solid foam disk 
sample. 
Taking into account the relatively small size 
of the ketoprofen molecule (see Fig. 1) (assuming 
extended conformation, a maximum length of 
approx. 1.48 nm can be calculated), it can be 
assumed that it may penetrate the mesopores 
present in the sample, particularly considering 
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that most mesopores in the solid foam disks are in 
the range of 10-50 nm diameter. This is of 
relevance with views on the incorporation 
(impregnation) of ketoprofen to the materials, 
which was carried out either by droplet addition 
of the drug solution on the materials or by their 
immersion in the drug solution. The most 
homogeneous results in the drug incorporation 
were obtained by immersing the solid foam disks 
in a solution with the drug, so this method was 
selected for further experiments. 
The net weight of ketoprofen incorporated to 
the materials from the three solutions studied (2 to 
10 wt%) varies from around 30 mg to 60 mg, 
respectively (Fig.4). Oral and rectal commercial 
forms usually contain between 50 and 200 mg of 
ketoprofen, so the new materials studied in the 
present work allow incorporating sufficient 
amount of active principle. 
In materials aimed for implantation with 
macroporous structures as the one shown, 
advantages of macroporosity come in two 
directions: In the first place, the interconnectivity 
between pores enhances water penetration and the 
shorter diffusion path in the polymer increases the 
release rate of hydrophobic molecules. This was 
observed by Lee et al. for Paclitaxel loaded 
Polylactide-co-glycolide foams (47). In the 
second place, the existence of macropores in the 
material promote bulk resorption of the implant 
(in case of biodegradable materials) (48) and 
favour cell colonisation and tissue ingrowth, thus 
promoting its integration within the host body. 
Previous works comparing drug release from 
biodegradable dense polymers or from their 
foamed analogues found enhanced drug delivery 
from the macroporous foams (47). 
Considering the pore size distribution of the 
sample in two main groups, mesopores and 
macropores, it could be speculated that the release 
kinetics of active principle incorporated to the 
solid would take place in two steps; a faster one 
corresponding to the release from the macropores, 
more accessible, and a slower one corresponding 
to the release from the mesopores, in which the 
“way out” of the active principle is longer 
(following the same principle as in exclusion 
chromatography resins). However, the potential 
contribution of mesopores to the ketoprofen 
release kinetics from the solid foams (Fig. 5) is 
not obvious, and that could be related to the small 
percentage of these lower-range pores.  
Release kinetics from the PS-DVB solid 
foams was found to be independent of the amount 
of drug loaded into the material in the range of 2-
10wt% studied, with a final release (after 24h) of 
80% in all cases. Comparison of the release 
curves from the 2wt% impregnated solid foam 
disks with the release from a solution containing 
the same amount of ketoprofen than the material 
clearly shows that the studied materials achieve a 
delayed release of the studied active principle.  It 
must also be underlined that the release from the 
solid foams did not reach the stationary stage after 
24h, reflecting potential for release of the entire 
drug. 
This can possibly be attributed, among other 
factors, to the contribution of the interconnected 
macroporosity to the fluid penetration throughout 
the bulk of the material, thus facilitating drug 
release. Such results indicate that the particular 
features of the 3D interconnected porous structure 
of the solid foams studied are relevant towards a 
controlled release of active principles. Therefore, 
in-vitro release of the lipophilic model drug 
studied from PS-DVB solid foams was efficient 
with a short lag-time and delayed release of the 
drug was achieved, suggesting a potentially useful 
pharmaceutical application of materials with 
similar morphology prepared from highly 
concentrated emulsions. 
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